Drawing for ARLINGTON SCIENTIFIC

USPTO serial 88277036

ARLINGTON SCIENTIFIC

Reviewed by CopyMark Law Group

Reg. 6081149Status 702Renewal
Filing date
Status date
Registration date
Jun 16, 2020
Examiner
BROWNING,LUKE CASH
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ARLINGTON SCIENTIFIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter M. de Jonge

Peter M. de Jonge Thorpe North & Western, LLP8180 South 700 East, Suite 350Sandy, UT 84070United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic enzyme immunoassay kit comprised of medical diagnostic reagents, syringes, test panels, and allergy control panels for use in disease detection and allergy detection; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection and allergy detectionACTIVEJul 18, 2019
009Computer hardware and recorded computer software used for automated plasma and serum sample processing in the medical field; medical instrument, namely, computer hardware and recorded computer software used to analyze and diagnose diseases and allergies in the field of medicine; medical instrument, namely, computer hardware and recorded computer application software used for automated plasma and serum sample processing, specifically, computer hardware and recorded computer application software used to acquire digital images of an antibody-antigen reaction causing aggregation of visual markers, for the purpose of assisting in the analysis and diagnosis of a disease state in serum samples; recorded computer software for analyzing and diagnosing a disease state in serum samples, which is sold as an integral component of computer hardware used to acquire digital images of an antibody-antigen reaction causing aggregation of visual markersACTIVEFeb 4, 2019
010Medical apparatus and instrument for diagnostic use and for medical testing that interprets enzyme immunoassays; medical procedure chair; medical lounge chair and related accessories, namely, armrest, privacy screen, tray, pillow, IV bag holder and IV sold as a unit used for medical patients sold as a unit; medical lounge chair and related accessories, namely, armrest, privacy screen, tray, pillow, IV bag holder and IV sold as a unit for use by blood and plasma donors all sold as a unit; medical lounge chair and accessories, namely, armrest, privacy screen, tray, pillow, IV bag holder and IV sold as a unit; nasal mucosal curette for the uniform collection of nasal mucosal specimens; medical apparatus and instrument for medical diagnosis of infectious disease; medical apparatus and instrument for diagnosing infectious disease and for medical testing that interprets enzyme immunoassaysACTIVESep 17, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 7, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 7, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 7, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 1, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jun 16, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 4, 2022PRA7REGISTERED - SEC. 7 REQUEST ABANDONED—
Nov 4, 2022PRANPOST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED—
Nov 4, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 6, 2022ES7RTEAS SECTION 7 REQUEST RECEIVED—
Dec 28, 2021PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Dec 23, 2021PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 16, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 14, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 13, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 11, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 3, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2019CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 30, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 19, 2019IUAFUSE AMENDMENT FILED—
Nov 19, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 5, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 30, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 30, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 29, 2019ALIEASSIGNED TO LIE—
Apr 16, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 15, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Apr 15, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 15, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 15, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 8, 2019DOCKASSIGNED TO EXAMINER—
Feb 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 29, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance